Compare Revvity Inc (RVTY) vs Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? Revvity Inc trades at $154.1 (market cap $16.98B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $70.34 (market cap $323.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 19.1× Revvity Inc's market cap, and Revvity Inc pays a 0.18% dividend while Vanguard Tax Managed Fund FTSE Developed Markets ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Vanguard Tax Managed Fund FTSE Developed Markets ETF for 131 Days on average.
| RVTY | VEA | |
|---|---|---|
Market Cap | $16.98B | $323.80B |
Volume | 1,456,900 | 17,001,112 |
Sector | Health | — |
52-Week High | $157.36 | $73.79 |
52-Week Low | $82.26 | $58.90 |
Typical Hold Time | 12 Days | 131 Days |
Enterprise Value | $19.30B | — |
Dividend Yield | 0.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.
The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.
VEA trades at $70.35 with minimal daily movement (+0.13%). Technical indicators show a bearish trend with strong sell signals from moving averages and oscillators, though RSI suggests potential oversold conditions. The ETF maintains competitive advantages with a low 0.03% expense ratio and higher dividend yield compared to peers. Recent institutional activity shows mixed sentiment with both significant position increases and reductions among major holders.
VEA offers cost-efficient exposure to developed international markets excluding the US, but faces headwinds from global market volatility. The bearish technical setup and mixed institutional positioning suggest cautious near-term outlook, though the fund's structural advantages provide long-term appeal for diversified international exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Vanguard Tax Managed Fund FTSE Developed Markets ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →
